Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Short term Debt (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Short term Debt for 4 consecutive years, with $2.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Short term Debt rose 4.49% to $2.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.0 million, a 4.49% increase, with the full-year FY2024 number at $2.0 million, up 6.04% from a year prior.
  • Short term Debt was $2.0 million for Q1 2025 at PROCEPT BioRobotics, roughly flat from $2.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.0 million in Q3 2024 to a low of $1.9 million in Q4 2023.
  • A 3-year average of $2.0 million and a median of $2.0 million in 2024 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: increased 6.04% in 2024, then rose 4.49% in 2025.
  • PROCEPT BioRobotics' Short term Debt stood at $1.9 million in 2023, then rose by 6.04% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Short term Debt are $2.0 million (Q1 2025), $2.0 million (Q4 2024), and $2.0 million (Q3 2024).